BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

BIO-FD&C Statistics

Total Valuation

BIO-FD&C has a market cap or net worth of KRW 142.26 billion. The enterprise value is 91.42 billion.

Market Cap	142.26B
Enterprise Value	91.42B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BIO-FD&C has 8.70 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	8.70M
Shares Outstanding	8.70M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	31.22%
Owned by Institutions (%)	0.16%
Float	5.19M

Valuation Ratios

The trailing PE ratio is 19.69.

PE Ratio	19.69
Forward PE	n/a
PS Ratio	7.56
PB Ratio	2.08
P/TBV Ratio	2.09
P/FCF Ratio	21.09
P/OCF Ratio	18.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.65, with an EV/FCF ratio of 13.56.

EV / Earnings	12.91
EV / Sales	4.86
EV / EBITDA	11.65
EV / EBIT	13.91
EV / FCF	13.56

Financial Position

The company has a current ratio of 16.08, with a Debt / Equity ratio of 0.00.

Current Ratio	16.08
Quick Ratio	15.18
Debt / Equity	0.00
Debt / EBITDA	0.04
Debt / FCF	0.05
Interest Coverage	129.96

Financial Efficiency

Return on equity (ROE) is 10.91% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE)	10.91%
Return on Assets (ROA)	5.96%
Return on Invested Capital (ROIC)	6.25%
Return on Capital Employed (ROCE)	9.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.27
Inventory Turnover	2.60

Taxes

In the past 12 months, BIO-FD&C has paid 1.18 billion in taxes.

Income Tax	1.18B
Effective Tax Rate	14.31%

Stock Price Statistics

The stock price has increased by +16.57% in the last 52 weeks. The beta is 0.65, so BIO-FD&C's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+16.57%
50-Day Moving Average	17,223.40
200-Day Moving Average	16,542.75
Relative Strength Index (RSI)	39.00
Average Volume (20 Days)	37,786

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-FD&C had revenue of KRW 18.82 billion and earned 7.08 billion in profits. Earnings per share was 830.92.

Revenue	18.82B
Gross Profit	13.08B
Operating Income	6.57B
Pretax Income	8.27B
Net Income	7.08B
EBITDA	7.85B
EBIT	6.57B
Earnings Per Share (EPS)	830.92

Balance Sheet

The company has 51.17 billion in cash and 335.27 million in debt, giving a net cash position of 50.84 billion or 5,846.22 per share.

Cash & Cash Equivalents	51.17B
Total Debt	335.27M
Net Cash	50.84B
Net Cash Per Share	5,846.22
Equity (Book Value)	68.46B
Book Value Per Share	8,014.80
Working Capital	53.37B

Cash Flow

In the last 12 months, operating cash flow was 7.69 billion and capital expenditures -940.39 million, giving a free cash flow of 6.74 billion.

Operating Cash Flow	7.69B
Capital Expenditures	-940.39M
Free Cash Flow	6.74B
FCF Per Share	775.64

Margins

Gross margin is 69.52%, with operating and profit margins of 34.92% and 37.64%.

Gross Margin	69.52%
Operating Margin	34.92%
Pretax Margin	43.93%
Profit Margin	37.64%
EBITDA Margin	41.72%
EBIT Margin	34.92%
FCF Margin	35.84%

Dividends & Yields

BIO-FD&C does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	4.98%
FCF Yield	4.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-FD&C has an Altman Z-Score of 23.95 and a Piotroski F-Score of 7.

Altman Z-Score	23.95
Piotroski F-Score	7